Abstract
Recently an increase in pump thrombosis has been reported in patients with continuous flow left ventricular assist devices (CFLVAD). The cause of this phenomenon remains unclear. Guidelines recommend that patients with a history of thrombophilia have a hypercoagulable assessment before implant (Class I, level C). The objective of this study was to estimate the frequency and analyze the impact of inherited and acquired hypercoagulable states in patients with CFLVADs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
